Paired Acute Invasive/Non-invasive Stimulation Trial
PAINS
Paired Transcranial Direct Current Stimulation/ Dorsal Root Ganglion Stimulation Trial
1 other identifier
interventional
16
1 country
1
Brief Summary
Chronic pain patients with implanted dorsal root ganglion stimulators will be randomized to receive transcranial direct current stimulation (tDCS) to the motor cortex, magneto-encephalographically (MEG) localized stimulation or sham stimulation to identify therapeutic efficacy of paired central and peripheral neuromodulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started May 2019
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 10, 2019
CompletedFirst Posted
Study publicly available on registry
May 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2019
CompletedApril 6, 2020
May 1, 2019
8 months
May 10, 2019
April 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in pain scores: 21-point pain scale rating
21-point pain scale rating
Immediately after 30 minutes of transcranial direct current stimulation
Secondary Outcomes (2)
Changes in EEG recordings
Immediately after 30 minutes of transcranial direct current stimulation
Changes in Facial Expression Recognition Performance
Immediately after 30 minutes of transcranial direct current stimulation
Study Arms (3)
Sham stimulation
SHAM COMPARATORMotor cortex stimulation
ACTIVE COMPARATORMEG-localized stimulation
EXPERIMENTALInterventions
tDCS produces hyper/hypopolarizing potentials in the cortex underlying the scalp electrodes and can increase/decrease the excitability of targeted brain regions.
Eligibility Criteria
You may qualify if:
- Patients who are willing and able to give consent to the study.
- Male or Female, aged 18 years or above with diagnoses of chronic pain.
- Treatment includes Spinal Cord Stimulation, Dorsal Root Ganglion stimulation, or peripheral analgesic stimulation.
You may not qualify if:
- Patients who do not wish to be in the study.
- Patients with metallic intracranial implants.
- Patients with extreme language barrier that cannot understand the purpose of the study despite the use of an interpreter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
John Radcliffe Hospital
Oxford, Oxfordshire, OX3 9DU, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alex Green, FRCS
University of Oxford
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2019
First Posted
May 17, 2019
Study Start
May 1, 2019
Primary Completion
December 20, 2019
Study Completion
December 20, 2019
Last Updated
April 6, 2020
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share
Patient diagnoses and demographics will be shared but identities kept anonymous